PPH
VanEck Pharmaceutical ETF
PPH
VanEck Pharmaceutical ETF
-
NAV$88.78
as of July 09, 2025 -
YTD RETURNS4.22%
as of July 09, 2025 -
Total Net Assets$589.36M
as of July 09, 2025 -
Total Expense Ratio0.36%
-
Inception Date12/20/2011
About PPH
VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
Overview
Why PPH
- Highly Liquid Companies: Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume
- Industry Leaders: Index methodology favors the largest companies in the industry
- Global Scope: Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation
Performance
Fees
Holdings
Portfolio
Sector Weightings (%) as at 06/30/2025
-
Sector
% of Net Assets -
Health Care
99.56 -
Other/Cash
0.44
Country Weightings (%) as at 06/30/2025
-
Country
% of Net Assets -
United States
62.99 -
United Kingdom
12.32 -
Switzerland
7.62 -
Denmark
7.56 -
France
4.50 -
Japan
2.98 -
Israel
1.59 -
Other/Cash
0.44